Search research articles
Contact Us
Filters
Showing results (1-10 of 127) with videos related to
Page
of 13
Sort By:
Dialogues in Clinical Neuroscience
|
October 29, 2011
Biochemical aspects of dementias
Christoph Hock
Neurobiology of Aging
|
May 16, 2002
Biochemical markers of Alzheimer's disease: wish and reality
Andreas Papassotiropoulos, Christoph Hock
JAMA
|
September 20, 2012
Physical restraint use in nursing homes
Florian Riese, Christoph Hock
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 16, 2008
Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapy
Roger M Nitsch, Christoph Hock
Neuro-Degenerative Diseases
|
August 16, 2006
Clinical observations with AN-1792 using TAPIR analyses
Christoph Hock, Roger M Nitsch
Journal of Alzheimer'S Disease : JAD
|
June 29, 2011
Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease
Jürgen Hänggi, Johannes Streffer, Lutz Jäncke, et al.
Pharmacopsychiatry
|
May 13, 2004
Esophageal dysfunction on psychotropic medication. A case report and literature review
Alessia S Maddalena, Mark Fox, Marc Hofmann, et al.
Geroscience
|
April 1, 2025
Voxel-wise insights into early Alzheimer's disease pathology progression: the association with APOE and memory decline
Maha Wybitul, Nicolas Langer, Christoph Hock, et al.
Neuro-Degenerative Diseases
|
December 29, 2006
Genetic association study on colony-stimulating factor 1 in Alzheimer's disease
M Axel Wollmer, Roger M Nitsch, Christoph Hock, et al.
Neurobiology of Aging
|
April 9, 2024
Trajectories of amyloid beta accumulation - Unveiling the relationship with APOE genotype and cognitive decline
Maha Wybitul, Andreas Buchmann, Nicolas Langer, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 127) with videos related to
Sort By:
Page
of 13
Dialogues in Clinical Neuroscience
|
October 29, 2011
Biochemical aspects of dementias
Christoph Hock
Neurobiology of Aging
|
May 16, 2002
Biochemical markers of Alzheimer's disease: wish and reality
Andreas Papassotiropoulos, Christoph Hock
JAMA
|
September 20, 2012
Physical restraint use in nursing homes
Florian Riese, Christoph Hock
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 16, 2008
Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapy
Roger M Nitsch, Christoph Hock
Neuro-Degenerative Diseases
|
August 16, 2006
Clinical observations with AN-1792 using TAPIR analyses
Christoph Hock, Roger M Nitsch
Journal of Alzheimer'S Disease : JAD
|
June 29, 2011
Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease
Jürgen Hänggi, Johannes Streffer, Lutz Jäncke, et al.
Pharmacopsychiatry
|
May 13, 2004
Esophageal dysfunction on psychotropic medication. A case report and literature review
Alessia S Maddalena, Mark Fox, Marc Hofmann, et al.
Geroscience
|
April 1, 2025
Voxel-wise insights into early Alzheimer's disease pathology progression: the association with APOE and memory decline
Maha Wybitul, Nicolas Langer, Christoph Hock, et al.
Neuro-Degenerative Diseases
|
December 29, 2006
Genetic association study on colony-stimulating factor 1 in Alzheimer's disease
M Axel Wollmer, Roger M Nitsch, Christoph Hock, et al.
Neurobiology of Aging
|
April 9, 2024
Trajectories of amyloid beta accumulation - Unveiling the relationship with APOE genotype and cognitive decline
Maha Wybitul, Andreas Buchmann, Nicolas Langer, et al.
Page
of 13